IDSA COVID-19 Guideline Part 1: Treatment and Management Guideline Summary

Guideline Central highly recommends you use Google Chrome while using this site.

For optimal experience please use Google Chrome.

Thank you.

By creating an account, I agree to receive occasional communications from Guideline Central. I understand I can opt out of these communications at any time by visiting my account page.

Already have an account? Login

Title

COVID-19 Guideline Part 1: Treatment and Management

Authoring Organization

Publication Month/Year

May 15, 2023

Document Type

Guideline

Country of Publication

Document Objectives

There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated practice guidelines on their use, based on critical evaluation of rapidly emerging literature

Inclusion Criteria

Male, Female, Adult, Older adult

Health Care Settings

Ambulatory, Hospital

Intended Users

Epidemiology infection prevention, nurse, nurse practitioner, health systems pharmacist, physician, physician assistant

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D017934 - Coronavirus

Keywords

Coronavirus, covid-19, COVID

TOOLS

Log In to use Notes
Increase Font Size
Decrease Font Size

Login

Forgot Password

Register